These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9739016)
1. MYCN is the only highly expressed gene from the core amplified domain in human neuroblastomas. Reiter JL; Brodeur GM Genes Chromosomes Cancer; 1998 Oct; 23(2):134-40. PubMed ID: 9739016 [TBL] [Abstract][Full Text] [Related]
3. Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma. Manohar CF; Salwen HR; Brodeur GM; Cohn SL Genes Chromosomes Cancer; 1995 Nov; 14(3):196-203. PubMed ID: 8589036 [TBL] [Abstract][Full Text] [Related]
4. High-resolution mapping of a 130-kb core region of the MYCN amplicon in neuroblastomas. Reiter JL; Brodeur GM Genomics; 1996 Feb; 32(1):97-103. PubMed ID: 8786126 [TBL] [Abstract][Full Text] [Related]
5. Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma. Kaneko S; Ohira M; Nakamura Y; Isogai E; Nakagawara A; Kaneko M J Cancer Res Clin Oncol; 2007 Mar; 133(3):185-92. PubMed ID: 17028906 [TBL] [Abstract][Full Text] [Related]
6. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas. Wang Q; Hii G; Shusterman S; Mosse Y; Winter CL; Guo C; Zhao H; Rappaport E; Hogarty MD; Maris JM Cancer Res; 2003 Apr; 63(7):1631-5. PubMed ID: 12670915 [TBL] [Abstract][Full Text] [Related]
7. High-resolution mapping of the N-myc amplicon core domain in neuroblastomas. Hiemstra JL; Schneider SS; Brodeur GM Prog Clin Biol Res; 1994; 385():51-7. PubMed ID: 7972237 [TBL] [Abstract][Full Text] [Related]
8. Amplification of a DEAD box gene (DDX1) with the MYCN gene in neuroblastomas as a result of cosegregation of sequences flanking the MYCN locus. Noguchi T; Akiyama K; Yokoyama M; Kanda N; Matsunaga T; Nishi Y Genes Chromosomes Cancer; 1996 Feb; 15(2):129-33. PubMed ID: 8834177 [TBL] [Abstract][Full Text] [Related]
9. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas. Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746 [TBL] [Abstract][Full Text] [Related]
10. Physical mapping of the DDX1 gene to 340 kb 5' of MYCN. Kuroda H; White PS; Sulman EP; Manohar CF; Reiter JL; Cohn SL; Brodeur GM Oncogene; 1996 Oct; 13(7):1561-5. PubMed ID: 8875996 [TBL] [Abstract][Full Text] [Related]
11. Two-dimensional DNA electrophoresis identifies novel CpG islands frequently coamplified with MYCN in neuroblastoma. Wimmer K; Zhu XX; Lamb BJ; Kuick R; Ambros P; Kovar H; Thoraval D; Elkahloun A; Meltzer P; Hanash SM Med Pediatr Oncol; 2001 Jan; 36(1):75-9. PubMed ID: 11464910 [TBL] [Abstract][Full Text] [Related]
12. Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization. Beheshti B; Braude I; Marrano P; Thorner P; Zielenska M; Squire JA Neoplasia; 2003; 5(1):53-62. PubMed ID: 12659670 [TBL] [Abstract][Full Text] [Related]
13. The neuroblastoma amplified gene, NAG: genomic structure and characterisation of the 7.3 kb transcript predominantly expressed in neuroblastoma. Scott DK; Board JR; Lu X; Pearson AD; Kenyon RM; Lunec J Gene; 2003 Mar; 307():1-11. PubMed ID: 12706883 [TBL] [Abstract][Full Text] [Related]
14. MYCN amplification and 17q in neuroblastoma: evidence for structural association. O'Neill S; Ekstrom L; Lastowska M; Roberts P; Brodeur GM; Kees UR; Schwab M; Bown N Genes Chromosomes Cancer; 2001 Jan; 30(1):87-90. PubMed ID: 11107180 [TBL] [Abstract][Full Text] [Related]
15. High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status. Westermann F; Henrich KO; Wei JS; Lutz W; Fischer M; König R; Wiedemeyer R; Ehemann V; Brors B; Ernestus K; Leuschner I; Benner A; Khan J; Schwab M Clin Cancer Res; 2007 Aug; 13(16):4695-703. PubMed ID: 17652624 [TBL] [Abstract][Full Text] [Related]
16. MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification. Spitz R; Hero B; Skowron M; Ernestus K; Berthold F Eur J Cancer; 2004 Dec; 40(18):2753-9. PubMed ID: 15571958 [TBL] [Abstract][Full Text] [Related]
17. Analysis of candidate gene co-amplification with MYCN in neuroblastoma. George RE; Kenyon R; McGuckin AG; Kohl N; Kogner P; Christiansen H; Pearson AD; Lunec J Eur J Cancer; 1997 Oct; 33(12):2037-42. PubMed ID: 9516849 [TBL] [Abstract][Full Text] [Related]
18. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma. Squire JA; Thorner PS; Weitzman S; Maggi JD; Dirks P; Doyle J; Hale M; Godbout R Oncogene; 1995 Apr; 10(7):1417-22. PubMed ID: 7731693 [TBL] [Abstract][Full Text] [Related]
19. Rearrangement in the coding region of the MYCN gene in a subset of amplicons in a case of neuroblastoma with MYCN amplification. Chen B; Jhanwar SC; Ladanyi M Diagn Mol Pathol; 2001 Jun; 10(2):100-4. PubMed ID: 11385318 [TBL] [Abstract][Full Text] [Related]
20. Assessment of MYCN amplification in neuroblastoma biopsies by differential polymerase chain reaction. Boerner S; Squire J; Thorner P; McKenna G; Zielenska M Pediatr Pathol; 1994; 14(5):823-32. PubMed ID: 7808981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]